Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01865747 |
|---|---|
| Brief Title: | A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma (METEOR) |
| First Submitted : | May 21, 2013 |
| First Submitted that Met QC Criteria : | May 30, 2013 |
| First Posted : | May 31, 2013 (Estimate) |
| Results First Submitted : | April 21, 2017 |
| Results First Submitted that Met QC Criteria : | June 19, 2017 |
| Results First Posted : | July 18, 2017 |
| Last Update Submitted that Met QC Criteria : | April 1, 2021 |
| Last Update Posted : | April 27, 2021 |